MicroRNA Expression in Cystic Fibrosis Airway Epithelium

Catherine M Greene1

  • 1Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland. cmgreene@rcsi.ie.

Biomolecules
|June 28, 2014
PubMed

Insights

MicroRNA (miR) expression changes in cystic fibrosis (CF) airways impact CFTR expression and immunity. Understanding these miR alterations offers potential for novel CF therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pulmonology

Background:

  • MicroRNAs (miRs) are key regulators of cellular protein content, primarily by downregulating target messenger RNA (mRNA).
  • Altered miR expression profiles are observed in the airway epithelium of individuals with cystic fibrosis (CF) compared to healthy controls.
  • These changes are critical for understanding CF pathophysiology and developing targeted therapies.

Purpose of the Study:

  • To discuss the implications of altered miR expression in CF airway epithelium.
  • To explore the impact of miRs on cystic fibrosis transmembrane conductance regulator (CFTR) expression, innate immunity, and toll-like receptor (TLR) signaling in CF.
  • To identify potential therapeutic strategies based on these miR alterations.

Main Methods:

  • Bioinformatic analysis of miR expression profiles in CF patient samples.
  • Review of existing literature on miR function in airway epithelium.
  • Discussion of signaling pathways affected by miRs in the context of CF.

Main Results:

  • Specific miRs are dysregulated in CF airways, affecting key cellular processes.
  • Altered miRs influence CFTR expression and function.
  • Changes in miR expression impact innate immune responses and TLR signaling pathways.

Conclusions:

  • Dysregulated miRs in CF airways have significant consequences for disease pathophysiology.
  • Targeting specific miRs presents a promising avenue for developing novel therapeutics for pulmonary manifestations of CF.
  • Further research into miR-based therapies could revolutionize CF treatment.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
655
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K